This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Rebecca S. Mason, MB, PhD; Peter G. Rohl, MB, FRACP; Dianne Lissner; Solomon Posen, MD, FRACP

Am J Dis Child. 1982;136(10):909-913.

Abstract
• Vitamin D metabolites were measured in 21 patients with hypophosphatemic osteomalacia of juvenile onset. In eight patients who had not received any antirachitic treatment, serum 25-hydroxyvitamin D (25-OH-D) and 1,25-dihydroxyvitamin D (1,25-[OH]₂D) values were normal, whereas serum 24,25-dihydroxyvitamin D (24,25-[OH]₂D) values were lower than in normal subjects. In 13 patients who were receiving ergocalciferol and oral elemental phosphorus, serum 25-OH-D and 24,25-(OH)₂D concentrations were elevated and serum 1,25-(OH)₂D values were low. The findings in untreated patients supported the hypothesis that vitamin D metabolism is abnormal in hypophosphatemic rickets/osteomalacia. The reduction of serum 1,25-(OH)2D levels with ergocalciferol and phosphate therapy gives further support to a therapeutic role for 1,25-(OH)₂D in this disorder.

(Am J Dis Child 1982;136:909-913)

Author Affiliations
From the Department of Medicine, Sydney (Australia) Hospital.

Footnotes
Reprint requests to Department of Medicine, Sydney Hospital, Macquarie St, Sydney 2001, Australia (Dr Posen).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Disordered Regulation of Renal 25-Hydroxyvitamin D-1{alpha}-Hydroxylase Gene Expression by Phosphorus in X-Linked Hypophosphatemic (Hyp) Mice
Azam et al.
Endocrinology 2003;144:3463-3468.
ABSTRACT | FULL TEXT